United Share Price

United Share Price

NASDAQ: UTHR | Large Cap | Healthcare
$578.81
-$4.22 (-0.72%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

United Stock Performance

Open
$583.35
Prev. Close
$583.03
Circuit Range
N/A
Day Range
$570.51 - $584.63
Year Range
$458.18 - $613.92
Volume
16,608
Average Traded
$578.04

United Share Price Today

As of 19 November 2026, United Therapeutics Corporation's share price is $578.81. The stock opened at $583.35, compared to its previous close of $583.03. During today's trading session, United Therapeutics Corporation's share price traded between $570.51 and $584.63, with an average price of $577.57. Over the past 52 weeks, the stock has recorded a high of $613.92 and a low of $458.18. In terms of performance, United Therapeutics Corporation's share price has risen by 4.05% over the last six months and is up 19.12% on a year-on-year basis.

United Share Price Chart

Line chart of the United price trend over the selected period. The price fell overall, ranging from 570.51 to 586.35, ending at 578.81.
$570.51$584.63
L
Show Current Price
H

United Stock Fundamentals & Key Indicators

Market Cap
$25.64B
PE Ratio (TTM)
20.21
Dividend Yield
0.00%
EPS (TTM)
$28.90
Revenue (TTM)
$3.18T
Return On Equity (TTM)
19.61%
Profit Margin
41.94%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-29.01%

United Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$790.20$781.50$783.30$832.50
Net Profit$364.30$274.90$333.00$258.60
Net Profit Margin46.10%35.18%42.51%31.06%
Income ChangeN/A-24.54%21.13%-22.34%

United Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1936.30$2327.50$2877.40$3182.70
Net Profit$727.30$984.80$1195.10$1334.70
Net Profit Margin37.56%42.31%41.53%41.94%
Income ChangeN/A35.40%21.35%11.68%

United Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets4177.53490.13616.02664.2
Current Assets3702.53873.93551.03380.3
Total Assets7880.07364.07167.06044.5
Non Current Liabilities223.2181.9377.8904.6
Current Liabilities560.6738.1804.4343.2
Total Liabilities783.8920.01182.21247.8
Shareholders' Equity7096.26444.05984.84796.7

United Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating1,561.21,327.1978.0802.5
Investing-551.3417.2-719.6-811.5
Financing-1,150.0-1,254.8-11.975.4

About United

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

United Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$594.00
$578.81
-3.27%
Oct 2026
$558.31
$598.38
+10.25%
Sep 2026
$513.98
$542.74
+2.75%
Aug 2026
$518.25
$528.19
+2.06%
Jul 2026
$542.63
$517.52
-4.46%
Jun 2026
$552.91
$541.70
-2.62%
May 2026
$566.16
$556.27
-2.69%
Apr 2026
$595.49
$571.64
-3.57%
Mar 2026
$511.55
$592.79
+17.59%
Feb 2026
$467.94
$504.12
+7.41%
Jan 2026
$489.06
$469.35
-3.62%
Dec 2025
$482.03
$487.00
+0.23%

United Share Price FAQs